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Abstract  Article Information 
 
Epidemiological study for Tuberculosis (TB) has been conducted in developed and 
developing countries to accesses the burden of the disease in their countries. 
However, this study was lacking in Nekemte and its surroundings, western Ethiopia. 
Therefore, present study was designed for cross-sectional study to generate 
preliminary epidemiological information on TB in Nekemte and its surroundings, 
Western Ethiopia. Clinical examination, chest X-ray, acid-fast staining, culture and 
polymerase chain reaction (PCR) were used in the study.  In addition, five years 
Nekemte Hospital and Nekemte Health center data were analyzed to assess the five 
years situation of TB, TB and HIV co-infection, and treatment outcome. The results of 
the study reveals that out of 30,945 TB cases registered from 2003-2008, 19,494 
(63%) had pulmonary TB (PTB) and 11,451 (37%) suffered from extra-pulmonary TB 
(EPTB) (χ2=81.936; p<0.001). From 19,494 registered PTB cases, smear positive PTB 
accounted for 2,462 (12.6%) of cases. The incidences of all forms of TB were 
gradually declining in the last five years, while the trend of smear positive TB was 
almost constant, according to retrospective analysis.  The disease was also showed to 
be more prevalent in 15- 64 age groups (χ2 =288.035; p<0.001). In addition, around 
11.5% of HIV positive patients were positive for TB.  During two months study period, 
520 new TB cases were registered. Out of these, 68 (13.1%) were smearing positive. 
The extrapolated annual incidence of clinically diagnosed and smear positive TB in the 
study area were 124.8/100,000 and 6.32/100,000 population, respectively. Out of 25 
isolate analyses by PCR, 15 were M. tuberculosis (Mtb), 4 were mixed with Mtb and 
M. bovis (Mb), 2 were unknown band and five were negative. The retrospective and 
present study showed that the significance of TB problem in the study area was not at 
the level to be undermined 
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Tuberculosis (TB), one of the most wide 
spread infectious disease, is the leading cause 
of death in the world.   It has been known in 
human history since ancient time (Zink et al., 
2003) and still it remains an important public 
health problem (WHO, 2008). According to the 
World Health Organization (WHO), currently, 
nearly 2 billion peoples (approximately one-third 
of the world's population) have been exposed to 
TB pathogen (WHO, 2008). Annually, 9.2 
million people become ill with TB, and 1.7     
million people die from the disease worldwide 
(CDC, 2005; WHO, 2008). Developing countries 
bear the highest burden of the TB epidemic. An 
estimation of 95% of TB cases and 98% of TB 
deaths occurs in the developing parts of world, 
where peoples are especially vulnerable to TB 
because of poor living conditions and limited 
access to treatment (WHO, 2006; Raviglione 
and O’Brien, 2004). Estimation shows that in 
sub-Sahara Africa alone, there are 1.3 million 
new cases of TB and 50,000 deaths annually 
(Porter and Adam, 1992). The young and most 
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productive segments of the population is 
seriously affected by the disease with the 
infection rate goes up to 50% (Styblo et al., 
1996). 
 
 In Ethiopia, TB is among the leading cause 
of mortality and morbidity (Azbite, 1991; FMOH, 
2008). Over one third of the population has 
been exposed to TB (WHO, 2005), and it has 
becoming a disease of major public health 
important, due to low health services coverage 
and poorly developed health information system 
in the country (WHO, 2005). Sero-prevalence 
rates of HIV among adult TB patients are 11% 
and 31% according to WHO report and more  
recent nation data from 1999 E.C., respectively 
(FMOH, 2008). 
 
Nekemte Hospital is a Referral hospital which 
is found in Nekemte Referral Town, East 
Wollega Zone, Western Ethiopia. It was 
estimated that over 2.5 million of people 
underwent treatment in this hospital. Currently, 
the Hospital gives diagnostic services for TB 
patients and it has not yet started the direct 
observed treatment short course (DOTS) 
program. Even though, there were no 
documents so far that shows specific figure of 
the TB problem in these part of Ethiopia, the 
hospital and other health center data show that 
the disease is a leading cause of mortality and 
morbidity. Similarly, the HIV/AIDS sero-
prevalence for this area was found to be high 
according to surveillance conducted in the past 
which may be one of a contributing factor for 
this high public important of TB in the district. 
This study was, therefore, designed to generate 
preliminary epidemiological information on TB in 




MATERIALS AND METHODS 
Study Area and Study Participants 
This cross-sectional study was conducted at 
Nekemte Referral Hospital, Western Ethiopia. 
The study participants were patients exhibiting 
the typical clinical signs and symptoms of TB 
visiting the out patients department (OPD) of 
the  Hospital that with  those have no history of 
starting anti-TB, able to expectorate sputum, 
above the age of five years, and voluntary to 
participate in the study. 
  
Sample Size 
Sample size was determined based on the 
period of data collection (two months). During 
these periods, 520 clinical suspected TB cases 
were visited the hospital and investigated. The 
sputum samples were collected and cultured for 
153 TB suspected patients because of limitation 
of resource to culture samples from all study 
patients. 
 
Diagnosis and Laboratory Procedure 
Clinical examination, chest radiography and 
microscopic examination of the study patient 
conducted at Nekemte Hospital as routine 
diagnostic procedure, and those patients 
positive for the disease was order to inter TB 
drug regime based on the discussion of 
physician. 
 
For isolate and characterize species of 
mycobacterium from PTB at the study area, the 
collected sputum sample was stored at deep 
freezer (-20 0C) immediately until transported to 
Aklilu Lemma Institute of Pathobiology, Addis 
Ababa University for TB culture after acid fast 
examination done at the study site. The stored 
sputum samples were transported using cold 
chains every seven days to the TB laboratory 
for culture and PCR processing. 
 
Lowenstein-Jensen (LJ) media was used for 
culturing the sputum samples. The sputum 
sample was decontaminated by adding equal 
volume of 4% NaOH solution, mixed very well 
and centrifuged at 3000 rpm for 10 min. The 
supernatant was decanted and the sediment 
was resuspended by mixing. Then a drop of 
phenol red was added to the suspension as 
indicator, and neutralized by 2 µl HCL through 
adding drop by drop until the color of the phenol 
red changed from purple to yellow. Then, one to 
two drops of the inoculums was added to the LJ 
medium. The inoculated tube was incubated in 
slant position with the tube screw caps closed 
for one week at 37 0C, and then put in up-right 
position until complete growth is seen in the 
some condition. 
 
For isolate and characterize species of 
mycobacterium from PTB, RD4 deletion typing 
was used based on method described by 
Cleaveland et al. (2007). The primers used in 
this study was RD4 flank FCTCGT 
CGAAGGCCACTAAAG; RD4 flan RAAGGC 
GAACAGATTCAGCAT; and RD4 intF; ACA 
GGCTGGCGAAGTATAGC. If RD4 is present 
(i.e M. tuberculosis and M. africanum) a 
productive size of 335bp (RD4-intF + RD4-
flankR) was obtained; if it is deleted (M. bovis); 
then a product of 446bp (RD4-flankF + RD4- 
flankR) was obtained.  




Retrospective Data Record Analysis 
Nekemte Hospital case book was used to 
assess the situation of TB in the last five years 
(2003-2008) in Nekemte and its surroundings. 
The forms of TB, sex and age pattern, as well 
as TB and HIV co-infection were assessed. 
Regarding treatment outcome of TB patients in 
Nekemte and its surrounding for the last five 
years (2003-2008), data were collected from 
Nekemte Health Center since the Nekemte 
Hospital was not yet started the DOTS 
programs and the data were not available. 
 
Ethical Consideration 
The study was ethically cleared by the 
Institutional Ethical Clearance Committee, Aklilu 
Lemma Institute of Pathobiology, Addis Ababa 
University. After the detailed purpose of the 
study was explained to each presumptive 
patient and those voluntary to participate in the 
study are confirmed their willingness by giving 
their oral or written consents. 
 
Statistical Analysis  
All data were analyzed by using SPSS for 
windows version 15.0 and Microsoft Excel. 
Descriptive statistics was used for analysis and 
expression of the result. Chi-square tests were 
used to compare difference between groups, 
and comparisons (difference) at p<0.05 were 
considered as statistically significant in this 
study. Strength of agreement between the TB 




Result of Retrospective Data Analysis 
 
Demographic Data  
Demographic data of TB patients were 
presented in Figure 1. Out of 30,945 TB cases 
registered in the last five years, 16,306 (52.7%) 
were males (χ
2
 =30.205; p<0.001), while out of 
all PTB and EPTB registered, 55.6% were 
females and 52% were males, respectively. The 
annual trends of TB for both sexes were 
gradually declined in the last five years.    
 
The mean age of all registered TB case was 
35.35.  In both form of TB (ETB and EPTB) the 
age group that most common affected by this 
disease was 15-44 (47.10%) followed with 45-
64 (35.50%), and 5-15 (14.39%). But the 
disease was less commonly in the age groups 
less than five years (0.74%)  and greater than  
sixty four years  age (2.72%) groups (χ2 = 
288.035; p<0.001) (Figure 2).  
 
In both sexes the disease was showed to be 
higher in 15-44 and followed with 45-64 ages 
group. However, in below 15 age groups, 
around 54.4% active TB recorded in female 





Pattern of Tuberculosis in Nekemte and its 
Surroundings  
Out of 30,945 TB cases that registered from 
2003-2008, 19,494 (63%) had PTB and 11,451 
(37%) suffered from EPTB (χ
2
=81.936; p<0.001). 
From 19,494 PTB cases in the last five years, 
smear positive PTB accounted for 12.6%. The 
trend of TB incidence in the last five years 
showed gradual decline per year with slight 
variation between years (Figure 3). As indicated 
by Figure 3, the incidence of PTB was higher 
(63%) than that of EPTB (χ
2 
=81.936; p<0.001). 
The trend of smear positive PTB was found to be 
almost constant in the last five years while smear 
negative PTB showed gradually declining 
(χ2=81.936; p<0.001). 
 
Trend of TB Treatment Outcomes in 
Nekemte and its Surrounding  
The trends of relapse, death and defaulter of 
TB chemotherapy in Nekemte and its 
surroundings were shown by the Figure 4. The 
numbers of relapse and death cases were 
generally showed increment in the last five 
years. Unlikely to the number of relapse and 
death cases, the defaulter cases showed 
gradual declining in the last five years 
(χ2=108.76, p<0.001). Regarding to failure 
cases in the study area, there was no any 
cases that recorded as treatment failure. 
 
Even though, the overall sex difference in 
treatment outcome was not showed any 
statistical significant difference between both 
sexes (χ
2
= 2.86; p>0.05), the relapse cases 
were slightly higher in females 16 (53.3%) than 
in males, while defaulter 46 (52.3%) and death 
44 (58.7%) cases were occurred highly in 
males.  
 





 Figure 1. Sex distribution of TB during 2003-08 in Nekemte and its surroundings.
 





















Figure 3. Trends of all form of TB, PTB, EPTB, smear positive and smear negative PTB that 
registered in the last five year in Nekemte and its surroundings. 
 





Figure 4. Trends of relapse, death and defaulter cases for TB treatment in Nekemte and its 
surroundings during 2003-08.  
 
 
Line 1= non template control, Line 2= Mtb positive control, 
Line 3 = Mb positvecontrol, Line 4-11 =sample, Line12 =1kb Ladder 
 
Figure 5. RD4 gel results of some representative samples. 
 
 
Prevalence of TB-HIV Co-infection in 
Nekemte and its Surroundings 
The data for TB and HIV co-infection were 
only available from September 2007 to October 
2008 at Nekemte Hospital. During this period, 
1302 HIV positive patients were tested for TB 
and out of these 146 (11.21%) were found to be 
positive for TB as indicated in Table 2, 
Therefore, the prevalence of TB and HIV co-
infection during this period of time in Nekemte 
and its surroundings was found to be 11.21% 
(146/1302). 
 
Incidence of Tuberculosis in Nekemte and 
its Surroundings 
On the base of clinical examination, 520 new 
TB cases were recorded during the two months 
of data collection period. Out of these, 68 
(13.1%) were positive for acid fast staining, and 
53% were males. The mean age of the study 
subjects were 32.5 and the disease was mostly 




 Extrapolation from two month record of TB 
patients, on average 3,120 new clinically 
diagnosed and 408 smear positive patients 
would visit the Nekemte Hospital annually. 
Thus, the annual incidence of clinically 
diagnosed and smear positive TB in Nekemte 
and its surrounding was 124.8/ 100,000 and 
16.32/ 100,000 population, respectively. 
 
Polymerase Chain Reaction (PCR)  
Twenty five (25) isolate were processed for 
identification by PCR (Figure 5), Out of these, 
14 (56%), 4 (16%) and 2 (8%) were identified to 
be Mtb, mixed infection of two species (Mtb and 
Mb) and unknown band, respectively. The 











The retrospective data analysis showed that 
out of all forms of TB registered in the last five 
years, 53% were males which was consistent 
with the report of other studies conducted in 
different part of the country (Kassu et al., 2007; 
Shargie and Lindtjorn, 2005) and the recent 
report of WHO (2008). This result reflects sex 
difference in the disease risk or access to 
treatment. The sex distribution of the forms of 
TB recorded in the present study is similar with 
that reported in Nepal (Chandrasekhar et al., 
2008).  
 
Even though, the mean age of all registered 
TB cases was 35.35, in both forms of TB, the 
age group that most commonly affected by this 
disease was 15-44 followed with 45-64. But the 
disease was less commonly registered in the 
others age groups. This result is consistent with 
the report of the other studies conducted in 
southern Ethiopia (Shargie and Lindtjorn, 2005), 
in Nepal (Chandrashekhar et al., 2008) and 
from the recent national report (FMOH, 2008). 
TB is prevalent in the age group 15-44 as this 
age group is sexually active may be co-infected 
with HIV, which is a risk factor for TB. Besides, 
TB is prevalent in male in all age group except 
in those years age below 15, which is 
consistent with  the globally age  pattern of TB 
where the number of male TB cases exceed 
that of  female in all age groups except in  
children (WHO, 2008). 
 
The finding from retrospective study indicated 
that the overall annual trends of all forms TB in 
the last five years (2003-2008) were observed 
to fall gradually. This is similar to the national 
and global TB incidence according to the recent 
report of WHO (2008). This could be due to the 
effect of DOTS program. This study also 
showed the higher incidence of PTB than the 
incidence of EPTB. This result supports the 
study that was conducted in south region 
Ethiopia where PTB accounted 67% of all from 
TB in the area (Shargie and Lindtjorn, 2005), 
and in northwestern Ethiopia where PTB 
accounted 64.2% from all form of TB, 
regardless of HIV status (Kassu et al., 2007). 
This result further confirms the presence of 
similarity in the forms of TB in different part of 
the country. Contrary to the trend of smear 
negative PTB, the trend of smear positive PTB 
was almost constant in the last five year. These 
could be due to the increasing quality of 
laboratory services and dissemination of 
HIV/AIDS in the study area.  
Presently, DOTS program was implemented 
in the study area but the relapse and death 
cases were generally increasing while the 
defaulters were gradually declining per years in 
responding to DOTS program, which was 
similar to other studies done in south Ethiopia 
(Shargie and Lindtjorn, 2005), in northwestern 
shewa (Seyoum, 2007) and in Jijiga district 
(Mohammed, 2007). Thus, this increasing in the 
incidence of relapse from these studies in 
different part of the country may be an 
indication for dissemination of the drug 
resistance strain of TB in the country as the 
national incidence MDR-TB in relapse cases 
was 12% (WHO, 2008). The other possible 
reason could be a rapid dissemination of 
HIV/AIDS in the area would increase the 
incidence of relapse and death cases while the 
implementation of DOTS, increasing of the 
community knowledge about TB and health 
facilities in area might have contributed for this 
change in the defaulter rate. 
 
Even though, overall sex difference in 
treatment outcome was not statically significant, 
there were low defaulter cases in females 
supporting the result of other studies (Shargie 
and Lindtjorn, 2005; Wally et al., 2001). The 
presence of slightly higher relapse rate in 
females and higher death rate in males were 
also found in this study of TB (Holmes et al., 
1998; Hudelson, 1996). 
 
The incidence of TB in HIV positive 
individuals was found to be 11.21% in this 
study, which is higher than the national 
incidence (6.3%), according to the recent WHO 
report (WHO, 2008). This high incidence of TB 
and HIV co-infection in Nekemte and its 
surroundings may be due to the high HIV/AIDS 
dissemination in the study area that would have 
the effect on TB progression.  
 
The extrapolated annual incidence of all from 
and smear positive TB in this study are lower 
than the national incidence of all form of TB per 
year (379/100,000 population) and smear 
positive TB (168/100,000 population) as the 
recent report of WHO (WHO, 2008). This may 
be due to the extrapolation may not indicate the 
real picture of TB in the study area as the 
incidence of TB is not evenly distributed with in 
12 month of a year. The other possible reason 
is the incidence of TB in the study area may be 
lower than the national TB incidence. 




PCR result showed that 56% infections were 
caused by Mtb while 16% were caused by 
mixed infection with Mtb and Mb. This finding 
showed lower proportion of Mtb infection as 
compared to other studies conducted in Addis 
Ababa with 98.37% (Bruchfeld et al., 2002) and 
in Nigeria around 85% (Cadmus et al., 2006) 
TB infection  was caused by Mtb.  
 
CONCLUSION 
Result of the retrospective study showed the 
significance of the disease in the study area. 
The trends of all forms of TB, and defaulters 
were gradually declining in the last five years, 
which may be a promising achievement in the 
control of the disease in this area. However, the 
disease was more commonly in the productive 
age (15-64) groups of the population thereby 
affecting the economic development. In 
addition, the detection rate (incidence of smear 
positive TB cases) was almost constant while 
relapse and death rate were rising in associated 
to dissemination of HIV in the area. Thus, 
farther detail study has to be done in future to 
identify the contributing factors and the strain of 
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